{"protocolSection":{"identificationModule":{"nctId":"NCT00123266","orgStudyIdInfo":{"id":"TG-M-003"},"organization":{"fullName":"ThromboGenics","class":"INDUSTRY"},"briefTitle":"Intra-arterial Microplasmin Administration in Patients With Acute Intracranial Vertebrobasilar Artery Occlusion","officialTitle":"An Open-label, Clinical Trial of Intra-arterial Microplasmin Administration in Patients With Acute Intracranial Vertebrobasilar Artery Occlusion","acronym":"MITI-IA"},"statusModule":{"statusVerifiedDate":"2014-04","overallStatus":"TERMINATED","whyStopped":"Sponsor's decision not to pursue development of uPLi for vascular conditions.","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2006-12"},"primaryCompletionDateStruct":{"date":"2007-07","type":"ACTUAL"},"completionDateStruct":{"date":"2008-08","type":"ACTUAL"},"studyFirstSubmitDate":"2005-07-21","studyFirstSubmitQcDate":"2005-07-21","studyFirstPostDateStruct":{"date":"2005-07-22","type":"ESTIMATED"},"lastUpdateSubmitDate":"2014-04-04","lastUpdatePostDateStruct":{"date":"2014-04-07","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"ThromboGenics","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"The purpose of the trial is to evaluate the safety of microplasmin as well as its ability to open blocked arteries to the brain in patients with acute stroke when given into the artery at the site of the blockage.","detailedDescription":"Patients with angiographically documented acute intracranial vertebrobasilar artery occlusion presenting within 24 hours of neurological symptom onset will be enrolled into this open-label trial. During study drug administration, angiograms will be repeated at regular intervals to determine degree of clot lysis."},"conditionsModule":{"conditions":["Stroke"],"keywords":["stroke","vertebrobasilar","basilar","Acute vertebrobasilar artery occlusion"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE2"],"designInfo":{"allocation":"NON_RANDOMIZED","interventionModel":"SINGLE_GROUP","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":2,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Active","type":"EXPERIMENTAL","interventionNames":["Drug: Microplasmin"]}],"interventions":[{"type":"DRUG","name":"Microplasmin","description":"2 mg/kg, IA over 75 mins","armGroupLabels":["Active"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Recanalization rate","timeFrame":"Day-7, Day-30 and Day-90"}],"secondaryOutcomes":[{"measure":"Clinical assessment","timeFrame":"Day-7, Day-30 and Day-90"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Patients with angiographically documented vertebrobasilar artery occlusion\n2. Initiation of study drug treatment within 24 hours of the onset of neurological symptoms\n3. Age 18-75 (inclusive).\n\nExclusion Criteria:\n\n1. Patients with coma \\> 6 hrs duration and complete loss of brain stem reflexes (corneal reflex, gag reflex, VOR, pupil reflexes) as measured at the last assessment before sedation/intubation\n2. Rapidly improving neurologic signs at any time before initiation of study drug administration.\n3. Known contrast agent-sensitivity\n4. Uncontrolled hypertension defined as a systolic blood pressure \\> 180 mm Hg or a diastolic blood pressure \\> 100 mm Hg on 3 separate occasions at least 10 minutes apart or requiring continuous IV therapy.\n5. History of stroke within the previous 6 weeks.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Gerhard Hamann, Prof. Dr","affiliation":"HSK Dr. Horst Schmidt Hospital","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"UniversitÃ¤tsklinikum Erlangen","city":"Erlangen","zip":"D-91054","country":"Germany","geoPoint":{"lat":49.59099,"lon":11.00783}},{"facility":"Universitatsklinikum Freiburg","city":"Freiburg","zip":"D-79106","country":"Germany","geoPoint":{"lat":47.9959,"lon":7.85222}},{"facility":"UniversitÃ¤tsklinikum des Saarlandes","city":"Homburg/Saar","zip":"66421","country":"Germany","geoPoint":{"lat":49.32637,"lon":7.33867}},{"facility":"UKSH Campus Kiel","city":"Kiel","zip":"24105","country":"Germany","geoPoint":{"lat":54.32133,"lon":10.13489}},{"facility":"Ludwig-Maximilians-University Hospital","city":"Munich","country":"Germany","geoPoint":{"lat":48.13743,"lon":11.57549}},{"facility":"HSK Dr. Horst Schmidt Hospital","city":"Wiesbaden","zip":"65199","country":"Germany","geoPoint":{"lat":50.08258,"lon":8.24932}},{"facility":"Sint Antonius Ziekenhuis","city":"Nieuwegein","zip":"3430 EM","country":"Netherlands","geoPoint":{"lat":52.02917,"lon":5.08056}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000001157","term":"Arterial Occlusive Diseases"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M4155","name":"Arterial Occlusive Diseases","asFound":"Artery Occlusion","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"Rare","name":"Rare Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"D000010958","term":"Plasminogen"}],"ancestors":[{"id":"D000005343","term":"Fibrinolytic Agents"},{"id":"D000050299","term":"Fibrin Modulating Agents"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"}],"browseLeaves":[{"id":"M13538","name":"Plasminogen","asFound":"Fractured","relevance":"HIGH"},{"id":"M8163","name":"Fibrinolytic Agents","relevance":"LOW"}],"browseBranches":[{"abbrev":"FiAg","name":"Fibrinolytic Agents"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}